CIBC World Markets’s Regenxbio RGNX Stock Holding History

CIBC World Markets’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,320	Closed	-$73.8K	–	1859
2025 Q1	$73.8K	Buy	+10,320	New	+$76.8K	﹤0.01%	1657

Other funds holding RGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

CIBC World Markets's RGNX Position: Q2 2025 in Review

CIBC World Markets sold out of Regenxbio (RGNX) in Q2 2025, closing a stake of 10,320 shares — an estimated $73.8K sold.

CIBC World Markets first reported a position in RGNX in Q1 2025 and held it in 1 quarter. The position peaked at $73.8K in Q1 2025. 159 funds tracked by Wall St. Rank hold RGNX as of Q2 2025.

CIBC World Markets reported no remaining Regenxbio position as of Q2 2025 after selling out during the quarter.
CIBC World Markets sold 10,320 Regenxbio shares in Q2 2025, an estimated $73.8K.
CIBC World Markets first reported a position in Regenxbio in Q1 2025 and held it in 1 quarter.
CIBC World Markets's Regenxbio position peaked at $73.8K in Q1 2025.
159 funds tracked by Wall St. Rank held Regenxbio as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.